GE HealthCare · 1 day ago
KOL and Advocacy Lead - Oncology
GE HealthCare is a purpose-driven team focused on advancing precision diagnostics in healthcare. The Oncology KOL and Stakeholder Engagement Lead will develop relationships with key opinion leaders and professional societies to promote oncology imaging technologies and enhance stakeholder engagement through educational initiatives and advocacy efforts.
AppsHealth CareHealth DiagnosticsHome ImprovementHome RenovationInternetMedical
Responsibilities
Establish connections with leading oncology and nuclear medicine KOLs to help inform commercial and marketing strategy
Identify KOLs who can provide expert opinions if GE Healthcare has a legitimate business need for the advice (e.g., for educational and advocacy initiatives)
Design and implement strategies to support the adoption of oncology imaging technologies for appropriate patients
Develop and manage relationships with professional societies and patient advocacy organizations
Represent the company at key industry events, forums, and working groups
Collaborate when appropriate on society-developed educational and advocacy initiatives, while respecting and maintaining the independence of the society/association
Design and implement patient-focused awareness strategies aligned with the product strategy
Create and execute educational programs tailored to imaging professionals and oncologists
Organize speaker programs, ad boards, and training sessions
Ensure alignment of educational materials with clinical needs and regulatory requirements
Develop awareness materials and programs to increase awareness of diseases, treatment, and technological advancements
Partner with internal cross-functional teams to create consistent and impactful messaging and communications tailored to stakeholder needs
Collaborate with advocacy and industry groups to design and execute awareness campaigns
Develop strategies to enhance industry standards and guidelines related to molecular imaging for oncology
Provide support for regulatory agency interactions and communications as needed
Lead initiatives to position the company as a thought leader in oncology molecular imaging
Partner with marketing, sales, clinical, and R&D teams to ensure alignment on messaging and strategy
Work with global teams to leverage resources and insights for regional strategy execution
Follow review and approval processes for any fee for service arrangements with healthcare professionals, healthcare institutions, patient advocacy organizations or patients
Ensure external communications/materials are approved through the appropriate process prior to use (e.g. advertising and promotional review/medical review)
Qualification
Required
Deep understanding of oncology, particularly breast oncology is a must, ideally with 7–10+ years and an advanced degree
Ability to travel up to 40% of the time
Proven experience in KOL engagement, advocacy, or professional society collaboration in the healthcare or pharmaceutical industry
Strong communication and relationship-building skills, with the ability to engage stakeholders at all levels
Expertise in planning and executing educational and promotional programs
Strategic thinking with a track record of driving initiatives that impact industry guidelines or standards
Excellent project management and organizational skills, with the ability to manage multiple initiatives simultaneously
Knowledge of regulatory and compliance requirements related to interactions with healthcare professionals, healthcare organizations and patient advocacy organizations
Ability to manage competing priorities and meet tight deadlines
Excellent problem-solving skills
Preferred
Marketing experience is strongly preferred
Benefits
Medical
Dental
Vision
Paid time off
A 401(k) plan with employee and company contribution opportunities
Life
Disability
Accident insurance
Tuition reimbursement
Company
GE HealthCare
GE Healthcare provides a wide range of medical technologies and services to healthcare providers and researchers. It is a sub-organization of General Electric.
Funding
Current Stage
Public CompanyTotal Funding
$5.52BKey Investors
Bill & Melinda Gates Foundation
2024-11-07Post Ipo Secondary· $1.17B
2024-09-12Post Ipo Secondary· $1.29B
2024-02-16Post Ipo Secondary· $1.07B
Leadership Team
Recent News
eeNews Europe
2026-01-09
Company data provided by crunchbase